Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean national health and nutrition examination survey

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Koo, Hyeon Kyoung ^a   Park, Joo Hyun ^a   Park, Hye Kyeong ^a   Jung, Hoon ^a   Lee, Sung Soon ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; RISK FACTOR; SARCOPENIA; AGED; COMPLICATION; LUNG; PATHOPHYSIOLOGY; SOUTH KOREA;

AGED; HEALTH SURVEYS; HUMANS; LUNG; MALE; OBESITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REPUBLIC OF KOREA; RISK FACTORS; SARCOPENIA;

EID: 84908562460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110448     Document Type: Article

References (23)

1. Roisin RR (2011) Global strategy for the diagnosis, management and prevention of COPD. Updated 2011. Bethesda, MD, USA. http://www.goldcopd.org/uploads/users/files/GOLDReport2011Feb21.pdf.
2. Wüst RC, Degens H (2007) Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis. 2(3): 289-300.
3. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012.
4. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. Dec; 160(6): 1856-61.
5. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, et al. (2002) Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. Sep; 20(3): 539-44.
6. Sahebjami H, Doers JT, Render ML, Bond TL (1993) Anthropometric and pulmonary function test profiles of outpatients with stable chronic obstructive pulmonary disease. Am J Med. May; 94(5): 469-74.
7. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, et al. (2007) Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest. Jul; 132(1): 164-9. Epub 2007 May 15.
8. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, et al. (2002) Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. Sep 15; 166(6): 809-13.
9. American Thoracic Society (1995) Standardization of Spirometry, (1994) Update. Am J Respir Crit Care Med 152: 1107-1136.
10. Choi JK, Paek DM, Lee JO (2005) Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 58: 230-242.
11. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, et al. (1990) Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 52: 214-218.
12. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50: 889-896.
13. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, et al. (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33: 1652-1654.
14. Kim JH, Hwang Bo Y, Hong ES, Ohn JH, Kim CH, et al. (2010) Investigation of sarcopenia and its association with cardiometabolic risk factors in elderly subjects. J Korean Geriatr Soc 14: 121-30.
15. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
16. The EuroQol Group (1990) EuroQol - a new facility for measurement of healthrelated quality of life. Health Policy 16: 199-208.
17. Wilke S, Janssen DJ, Wouters EF, Schols JM, Franssen FM, et al. (2012) Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study, Health and Quality of Life Outcomes 10: 98.
18. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, et al. (1999) Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54: 581-586.
19. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, et al. (1997) Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 127: 1072-1079.
20. Miravitlles M, Ferrer M, Pont A, Viejo JL, Masa JF, et al. (2005) Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 99: 985-995.
21. Chin SO, Rhee SY, Chon S, Hwang YC, Jeong IK, et al. (2013) Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS One. 8(3): e60119. Epub 2013 Mar 22.
22. Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, et al. (2009) Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). Aug; 33(8): 885-92. Epub 2009 Jun 30.
23. Chen CZ, Ou CY, Wang WL, Lee KS, Lee DR, et al. (2012) Using postbronchodilator FEV1 is better than pre-bronchodilator FEV1 in evaluation of COPD severity. COPD 9: 276-280.